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ANTIBODY RESPONSE TO HEAT-INACTIVATED HEPATITIS B VACCINE (CLB-3mg) IN 
HEMODIALYSIS PATIENTS AND OCCUPATIONAL RISK PERSONNEL: A ONE YEAR FOLLOW-UP 
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S U M M A R Y 
I m m u n e response a g a i n s t h e p a t i t i s B v a c c i n e ( C L B 3mg) w a s e v a l u a t e d i n 59 
h e m o d i a l y s i s p a t i e n t s a n d 20 o c c u p a t i o n a l r i s k p e r s o n n e l . S e r o c o n v e r s i o n w a s i n d u -
c e d i n 52.5% a n d 70.0% respec t i ve l y . T w e l v e m o n t h s after the f i rs t dose , 37.5% of 
p a t i e n t s a n d 60.0% of o c c u p a t i o n a l r i s k p e r s o n n e l h a d de tec tab le a n t i - H B s l eve l . 
A n t i b o d y l eve l w a s e x p r e s s e d i n s a m p l e ra t io u n i t s ( S R U ) . C o n s i d e r i n g on l y the 
r e s p o n d e r s , i n the p a t i e n t s g r o u p 38.7% h a d a l ow a n t i - H B s response (2.1-9.9 S R U ) 
32.3% a m e d i u m r e s p o n s e (10-99.9 S R U ) a n d 29.0% a h i g h r e s p o n s e (>100 S R U ) 
wh i l e i n o c c u p a t i o n a l r i s k p e r s o n n e l these v a l u e s were 14.3%, 64.3% a n d 21.4% respec-
t i ve ly . T h e a u t h o r s s u g g e s t the use of H B V v a c c i n e s w i t h m o r e e l eva ted H B s A g 
c o n c e n t r a t i o n or a re in fo rced i m m u n i z a t i o n s c h e d u l e to i m p r o v e the a n t i - H B s res-
p o n s e no t on l y for p a t i e n t s b u t a l so for h e a l t h y p e r s o n s . 
K E Y W O R D S : H e p a t i t i s B v a c c i n e ; I m m u n e R e s p o n s e ; H e m o d i a l y s i s . 
I N T R O D U C T I O N 
T h e p r o p h y l a x i s of the h e p a t i t i s B in fec t ion 
b y v a c c i n a t i o n h a s b e e n a m a j o r b r e a k t h r o u g h 
i n the con t ro l of th i s d i sease . 
T h e use of v a c c i n e is r e c o m m e n d e d in n e m o 
d i a l y s i s u n i t s b e c a u s e of the h i g h r i s k of d i s s e m i -
n a t i o n of h e p a t i t i s B v i r u s ( H B V ) d u e to the h i g h 
f r e q u e n c y of c h r o n i c c a r r i e r s a m o n g p a t i e n t s 
w i t h r e n a l fa i lu re (13). 
S e v e r a l s t u d i e s h a v e d e m o n s t r a t e d the effi-
c a c y of d i f ferent p l a s m a d e r i v e d v a c c i n e s ( H e v a c 
B , P a s t e u r ; H e p t a v a x , M S D ) i n the p r e v e n t i o n 
of h e p a t i t i s B i n h e m o d i a l y s i s c e n t e r s 6 7 a n d 
a m o n g h i g h r i s k g r o u p s s u c h as c h i l d r e n l i v i n g 
i n e n d e m i c a r e a s 1 7 a n d m a l e h o m o s s e x u a i s 1 8 . 
I n 1981, B R U M M E L H U I S et a l . 2 d e s c r i b e d 
a s i m p l i f i e d m e t h o d of p r e p a r a t i o n of hea t - i nac -
t i v a t e d h e p a t i t i s B v a c c i n e ( C L B , N e t h e r l a n d s ) . 
T h e e f f i cacy a n d i m m u n o g e n i c i t y of th i s v a c c i n e 
were d e m o n s t r a t e d i n h e a l t h y vo lun tee rs a t low 
r i s k 1 5 a n d in s o m e h i g h r i s k g r o u p s 5 8 . 
T h i s p a p e r d e s c r i b e s the e v a l u a t i o n of the 
i m m u n e response in h e m o d i a l y s i s pa t i en t s a n d 
o c c u p a t i o n a l r i s k p e r s o n n e l a g a i n s t C L B - 3 f t g 
v a c c i n e . 
M A T E R I A L S A N D M E T H O D S 
V a c c i n e : T h e C L B v a c c i n e c o n t a i n s 2 2 n m 
p a r t i c l e s of H B s A g of two d i f ferent s u b t y p e s , a d 
(1) D e p a r t a m e n t o d e V i r o l o g i a . F u n d a ç ã o O s w a l d o C r u z , R i o de J a n e i r o , B r a z i l 
(2) C D R — C l í n i c a de D o e n ç a s R e n a i s , R i o de J a n e i r o . 
(3) B i o - M a n g u i n h o s , F u n d a ç ã o O s w a l d o C r u z , R i o de J a n e i r o , B r a z i l . 
A d d r e s s for c o r r e s p o n d e n c e : C l a r a F u m i k o T a c h i b a n a Y o s h i d a . F u n d a ç ã o O s w a l d o C r u z . D e p a r t a m e n t o de V i r o l o g i a . 
A v . B r a s i l , 4365. C E P 21040 R i o de J a n e i r o , R J . , B r a s i l . 
a n d ay , pur i f i ed by s e p a r a t i o n m e t h o d s u s e d for 
i so la t i on of p l a s m a c o m p o n e n t s . T h e v a c c i n e is 
h e a t i n a c t i v a t e d , a b s o r b e d to a l u m i n i u m p h o s ­
p h a t e a n d the final s u s p e n s i o n c o n t a i n s 3#*g of 
H B s A g per dose . T h i s v a c c i n e w a s d e v e l o p e d 
b y the C e n t r a l L a b o r a t o r y of the N e t h e r l a n d s 
R e d C r o s s B l o o d T r a n s f u s i o n S e r v i c e ( C L B ) , a n d 
w a s k i n d l y p r o v i d e d to be e v a l u a t e d in our he 
m o d i a l y s i s p a t i e n t s a n d o c c u p a t i o n a l r i s k perso­
nne l . T h e v a c c i n e w a s k e p t a t 4°C i n our l a b o r a ­
tory un t i l i s s u e d for i n o c u l a t i o n . 
P a r t i c i p a n t s : T h e v a c c i n e w a s tes ted i n a 
to ta l of 59 p a t i e n t s (38 m a l e s ) a t 5 h e m o d i a l y s i s 
cen te rs . T h e m e a n a g e w a s 41 ± 1 3 y e a r s a n d 
38% h a d been s u b m i t t e d to h e m o d i a l y s i s for m o ­
re t h a n one year . T w e n t y o c c u p a t i o n a l r i s k pe r 
sonne l (8 m a l e s ) w i t h a m e a n age of 28 ± 8 were 
a lso v a c c i n a t e d . 
A l l p a r t i c i p a n t s were v o l u n t e e r s a n d o n l y 
those w h o were n e g a t i v e for a n y H B V m a r k e r 
were s e l e c t e d for v a c c i n a t i o n . A f t e r the b e g i 
n n i n g of v a c c i n a t i o n , b l o o d s p e c i m e n s were ob 
t a i ned f rom a l l s u b j e c t s a t m o n t h l y i n t e r va l s d u 
r i ng a pe r i od of one y e a r to be tes ted for H B s A g 
a n d a n t i - H B s . 
I m m u n i z a t i o n p r o t o c o l : T h r e e v a c c i n e do 
ses of 3/jLg were a d m i n i s t e r e d a t one m o n t h inter­
v a l s b y i n t r a m u s c u l a r i n j ec t i on in o c c u p a t i o n a l 
r i s k p e r s o n n e l . I n h e m o d i a l y s i s p a t i e n t s the v a c ­
c ine w a s a d m i n i s t e r e d i n four doses of 3/xg, g i v e n 
at 0, 1,2 a n d 5 m o n t h s . T h e s i te of i n j ec t i on w a s 
the de l t o i d reg ion . 
L a b o r a t o r y m e t h o d s : H B s A g w a s tes ted b y 
e n z y m e i m m u n o a s s a y w i t h r e a g e n t s p r e p a r e d 
H s m o ^ i o l y s f s P a t i e n t s N • 3 9 
F i g . 1 — A n t i - H B s r e s p o n s e i n S R U in hem< 
i n ou r l abo ra to r y 3 . A n t i - H B c a n d a n t i - H B s were 
pe r fo rmed u s i n g so l i d p h a s e r a d i o i m m u n o a s s a y 
( A b b o t t L a b o r a t o r i e s , U S A ) . T h e l eve l of an t i -
H B s w a s e x p r e s s e d in s a m p l e ra t io u n i t s ( S R U ) , 
w h i c h w a s c a l c u l a t e d b y the c o u n t s per m i n u t e 
of the s a m p l e over the m e a n c o u n t s per m i n u t e 
of 7 n e g a t i v e con t ro l s . A n a n t i - H B s leve l g rea te r 
t h a n 2.1 S R U in a t l eas t two s e q u e n t i a l s a m p l e s 
w a s c o n s i d e r e d a s e r o c o n v e r s i o n . A low response 
w a s c o n s i d e r e d a n a n t i b o d y l eve l be tween 2.1 
a n d 9.9 S R U ; a m e d i u m r e s p o n s e b e t w e e n 10 
a n d 99.9 S R U a n d a h i g h r esponse e q u a l or over 
100 S R U . 
S t a t i s t i c a l m e t h o d s : T h e c h i - s q u a r e tes t 
w a s u s e d to c o m p a r e the f r equency of a n t i - H B s 
i n b o t h g r o u p s s t u d i e d (a = 0.05). 
R E S U L T S 
T h e a n t i - H B s s e r o c o n v e r s i o n i n d u c e d b y he­
pa t i t i s B v a c c i n e w a s de tec ted i n 52.5% of h e m o ­
d i a l y s i s p a t i e n t s a n d in 70.0% of o c c u p a t i o n a l 
r i s k pe r sonne l . T h i s d i f ference w a s n o t s ta t i s t i ­
c a l l y s i g n i f i c a n t . A m o n g p a t i e n t s , 20.3% h a d a 
l ow a n t i b o d y r e s p o n s e ( g e o m e t r i c m e a n t i ter , 
G M T = 6.8), 16.9% a m e d i u m r e s p o n s e ( G M T 
= 40.0) , a n d 15.3% a h i g h r e s p o n s e ( G M T = 
393.0), c o n s i d e r i n g the m a x i m u m a n t i b o d y leve l 
deve loped . T h e r e m a i n i n g 47.5% d i d no t s h o w 
a n y a n t i - H B s response d u r i n g the one yea r fo­
l l o w - u p . A m o n g o c c u p a t i o n a l r i s k p e r s o n n e l , 
10.0% h a d low r e s p o n s e ( G M T = 6.2), 45.0% a 
m e d i u m response ( G M T = 28.0), 15.0% a h i g h 
r esponse ( G M T = 493.5) a n d 30.0% fa i l ed to res­
p o n d to the v a c c i n e . T h e s e r e s u l t s are s h o w n 
i n f igure 1. 
H i g h R i s k Pwrsonns l N • 20 
l y s i s p a t i e n t s a n d o c c u p a t i o n a l r i s k p e r s o n n e l . 
C o n s i d e r i n g on l y the r e s p o n d e r s , i n the p a 
t ien ts g r o u p , the v a c c i n e i n d u c e d a low response 
i n 38.7%, a m e d i u m r e s p o n s e i n 32.3% a n d a h i g h 
r esponse i n 29.0%, wh i l e i n o c c u p a t i o n a l r i s k pe r 
s o n n e l , these v a l u e s were 14.3%, 64.3% a n d 21.4% 
respec t i ve l y . 
I n the p a t i e n t s g r o u p , the p e r c e n t a g e of an t i -
H B s r esponde rs d e c r e a s e d w i t h age . I n those u n ­
der 15 y e a r s o l d , 75.0% r e s p o n d e d to the v a c ­
c i ne a p ropo r t i on w h i c h d e c r e a s e d g r a d u a l l y to 
14.0% i n those a g e d over 61 y e a r s o ld ( F i g . 2). 
T h e t ime of a p p e a r a n c e of a n t i - H B s i n p a ­
t ients va r ied f rom 1 to 9 m o n t h s after the begi ­
n n i n g of v a c c i n a t i o n ; 64.5% of the r e s p o n d e r s 
d e v e l o p e d a n t i H B s w i t h i n t h e f i r s t t h r e e 
m o n t h s after the f i rs t dose ; 12.9% deve loped be t 
w e e n the t h i r d a n d fifth m o n t h w h e n the four th 
dose of v a c c i n e (day 150) w a s a d m i n i s t e r e d a n d 
a fu r ther 22.6% b e c a m e a n t i H B s pos i t i ve after 
the fifth m o n t h . A l t h o u g h the m a x i m u m an t i -
H B s r esponse s h o w e d a w ide v a r i a t i o n i n 67.7% 
it a l w a y s o c c u r r e d af ter the fou r th dose (f i f th 
m o n t h ) . T h e c u m u l a t i v e f r equency of an t i H B s 
a p p e a r a n c e a n d m a x i m u m response re la ted to 
t i m e of v a c c i n a t i o n are s h o w n i n fig. 3. I n the 
o c c u p a t i o n a l r i s k g r o u p , a n t i b o d y d e v e l o p e d 
over a sho r te r pe r i od , f rom 1 to 3 m o n t h s after 
the first dose , a n d 85.7% of t h e m s h o w e d m a x i ­
m u m r e s p o n s e be tween 3 a n d 6 m o n t h s ( F i g . 3). 
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F i g . 2 — A n t i b o d y r e s p o n s e to H e p a t i t i s B v a c c i n e i n h e m o d i a l y s i s p a t i e n t s re la ted to t h e age. 
T w e l v e m o n t h s af ter the f i rs t dose , a n t i - H B s 
l eve l d e c r e a s e d i n b o t h g r o u p s . I n the p a t i e n t s 
g r o u p , ou t of 28 r e s p o n d e r s , o n l y 21 (75.0%) s t i l l 
h a d a n t i b o d y a t t h i s t ime , e x c l u d i n g 3 p a t i e n t s 
w h o d i e d . I n the g r o u p of h i g h r e s p o n d e r s a l l 
r e m a i n e d p o s i t i v e , b u t the l eve l of a n t i - H B s de­
c r e a s e d m a r k e d l y . A m o n g 10 m e d i u m r e s p o n 
de rs , 3 b e c a m e n e g a t i v e i n the pe r i od of the fo-
l l ow-up a n d the a n t i b o d y l eve l a l so d e c r e a s e d 
i n the r e m a i n i n g 7 r e s p o n d e r s . F r o m 12 p a t i e n t s 
w h o h a d l ow r e s p o n s e , four b e c a m e n e g a t i v e , 
one d i ed a n d the r e m a i n i n g 7 h a d v e r y low an t i ­
b o d y leve ls af ter one y e a r ( T a b l e I ) . 
I n the o c c u p a t i o n a l r i s k p e r s o n n e l , a l l h i g h 
a n d m e d i u m r e s p o n d e r s r e m a i n e d p o s i t i v e af ter 
the one y e a r fo l low-up a n d o n l y two w h o h a d 
d e v e l o p e d low t i ters b e c a m e n e g a t i v e d u r i n g the 
p e r i o d of s t u d y ( T a b l e I ) . 
T A B L E I 
D e c r e a s e af ter 12 m o n t h s of a n t i - H B s r e s p o n s e to h e p a t i t i s B v a c c i n e ( C L B - 3 / t g ) i n h e m o d i a l y s i s p a t i e n t s a n d o c c u p a t i o n a l 
r i s k p e r s o n n e l 
H e m o d i a l y s i s p a t i e n t s O c c u p a t i o n a l r i s k p e r s o n n e l 
M a x i m u m r e s p o n s e 12 m o . a f ter 1st d o s e M a x i m u m r e s p o n s e 12 m o . a f ter 1st d o s e 
S R U N ( % ) G M T N ( % ) G M T N ( % ) G M T N ( % ) G M T 
2.1 - - 9 . 9 12/59 (20.3) 6.8 7*/56 (12.5) 3.2 2/20 (10.0) 6.2 0/20 (0) 0 
10 — 99.9 10/59 (16.9) 40.0 7/56 (12.5) 11.3 9/2 (45.0) 28.0 9/20 (45.0) 5.5 
> 100 9/59 (15.3) 393.0 7** /56 (12.5) 32.7 3/20 (15.0) 493.5 1/20 (15.0) 152.5 
31/59 (52.5) 21/56 (37.5) 14/20 (70.0) 12/20 (60.0) 
* 1: p a t i e n t d i e d 
* * 2: p a t i e n t s d i e d 
D I S C U S S I O N 
I n g e n e r a l , a n t i b o d y r e s p o n s e i n p a t i e n t s 
w i t h c h r o n i c r e n a l fa i lu re is lower t h a n i n h e a l t h y 
p e r s o n s 1 6 . Neve r t he l ess , a h i g h degree of p ro tec-
t i on a g a i n s t h e p a t i t i s B i n fec t i on h a s been repor 
ted i n s e v e r a l t r i a l s of H B V v a c c i n e ca r r i ed ou t 
i n s o m e g r o u p s a t r i s k , i n c l u d i n g h e m o d i a l y s i s 
p a t i e n t s 6 7 1 7 1 8 . S t u d i e s w i t h C L B - 3 / x g v a c c i n e , 
h a v e d e m o n s t r a t e d s e r o c o n v e r s i o n r a t e s r a n -
g i n g f rom 60 to 88% in s u c h p a t i e n t s 1 1 1 6 . I n the 
p resen t s t u d y , t h i s ra te (52.2%) w a s low c o m p a -
red w i t h o the r s t u d i e s . A f t e r 12 m o n t h s , o n l y 
37.5% of p a t i e n t s m a i n t a i n e d de tec tab le an t i bo -
d y l eve l s , wh i l e i n o ther s t u d i e s the c o m p a r a b l e 
p ropo r t i on were of 58% to 80%. I n the o c c u p a -
t i ona l r i s k g r o u p a s e r o c o n v e r s i o n ra te of 70% 
w a s o b t a i n e d , w i t h 60% s t i l l p o s i t i v e af ter one 
year . T h i s i s a lso lower t h a n i n o ther s t u d i e s as 
repor ted b y D E S M Y T E R et a l . (1983), w h o s h o 
wed a 100% s e r o c o n v e r s i o n ra te a n d m a i n t e n a n -
ce of a n t i b o d y i n 98% af ter a pe r i od of one yea r 9 . 
I t i s no t c l ea r w h e t h e r these l ess s a t i s f a c t o r y 
resu l t s c a n be a t t r i b u t e d to d i f fe rences of v a c -
c i ne p o t e n c y ( b a t c h to b a t c h v a r i a t i o n or d e g r a -
d a t i o n d u r i n g s t o r a g e or t r a n s p o r t ) or of h o s t 
r e s p o n s e s of the s u b j e c t s u n d e r s t u d y . 
O n e c a s e of H B V in fec t i on o c c u r r e d i n a low 
r e s p o n d e r p a t i e n t 11 m o n t h s af ter v a c c i n a t i o n 
w h i l e c i r c u l a t i n g a n t i - H B s w a s s t i l l d e t e c t e d . 
T h e m a x i m u m a n t i b o d y r e s p o n s e w a s 9.1 S R U 
i n the s e v e n t h m o n t h a n d h a d d e c r e a s e d to 2.5 
S R U a t t h e t i m e of i n f e c t i o n . A t p r e s e n t , 7 
m o n t h s af ter i n fec t i on , t h i s p a t i e n t r e m a i n s H B -
s A g pos i t i ve i n a c h r o n i c ca r r i e r s t a te . A m o n g 
the o c c u p a t i o n a l r i s k g r o u p , one c a s e of c l i n i c a l 
h e p a t i t i s o c c u r r e d i n a non - responde r , w i t h H B -
s A g a p p e a r i n g 8 m o n t h s af ter the f i rs t d o s e of 
v a c c i n e a n d c l i n i c a l d i s e a s e 1 m o n t h la ter . T h e 
c l e a r a n c e of H B s A g w a s o b s e r v e d af ter 6 m o n t h s 
of a n t i g e n e m i a b u t n o a n t i - H B s r e s p o n s e h a s 
b e e n so far e l i c i t ed u p to 4 m o n t h s af ter c l e a -
r a n c e . 
T h e re in fo rced v a c c i n a t i o n s c h e d u l e a p p l i -
c a b l e i n h e m o d i a l y s i s p a t i e n t s h a s b e e n d e m o n s -
t r a t e d to i n d u c e a b e t t e r i m m u n e r e s p o n s e 4 . 
I n d e e d , the f ou r t h d o s e g i v e n to p a t i e n t s n o t 
o n l y i n c r e a s e d the s e r o c o n v e r s i o n ra te b u t i t s 
m o r e n o t i c e a b l e effect w a s in the i nc rease of an t i -
b o d y leve ls ( F i g . 3). 
I t h a s been repor ted i n s o m e ef f icacy t r ia l s 
t ha t on l y those p e r s o n s w h o r e s p o n d we l l , w i th 
a t l e a s t one s e r u m s a m p l e p r e s e n t i n g m o r e t h a n 
10 S R U , are p ro tec ted f rom H B V i n f e c t i o n 1 0 1 4 . 
C o n s i d e r i n g t h i s c r i t e r i o n , i n o u r s t u d y o n l y 
32.2% of p a t i e n t s a n d 60.0% of h i g h r i s k perso-
n n e l d e v e l o p e d p r o t e c t i v e a n t i - H B s l e v e l s , 
w h i c h d e c r e a s e d to 13.5% a n d 25.0% respec t i ve l y 
after twe lve m o n t h s . 
I n a t r i a l c o n d u c t e d w i t h P a s t e u r v a c c i n e 
i n a F r e n c h h e m o d i a l y s i s un i t , 5 p a t i e n t s w h o 
were low or n o n - r e s p o n d e r s d u r i n g a pe r iod of 
one y e a r , d e v e l o p e d c o n s i d e r a b l e a n t i - H B s le-
ve l s af ter a boos te r i n j e c t i o n 1 . F r o m our resu l t s , 
i t w o u l d a p p e a r des i r ab le to a d m i n i s t e r a boos -
ter dose no t on l y i n p a t i e n t s b u t a l so i n h e a l t h y 
p e r s o n s to e l i c i t a m o r e pe rs i s t en t a n t i b o d y le-
v e l . A l t e r n a t i v e l y , for i m m u n o s u p p r e s s e d i n d i v i -
d u a l s , H B V v a c c i n e w i t h h i g h e r H B s A g c o n c e n -
t ra t ion ( C L B — 27 fig, Pas teur -10 §ig, M S D - 4 0 fig) 
h a v e b e e n e m p l o y e d w i t h a s i g n i f i c a n t i m p r o v e -
m e n t i n p r o t e c t i o n l e v e l 1 1 1 2 . B e t t e r r esu l t s m i g h t 
be o b t a i n e d w i t h the use of these m o r e i m m u n o -
gen i c v a c c i n e s a n d we s u g g e s t the i r e v a l u a t i o n 
i n our c o u n t r y . 
R E S U M O 
R e s p o s t a de a n t i c o r p o c o n t r a v a c i n a de hepa-
t i te B i n a t i v a d a p e l o c a l o r ( C L B - 3 m g ) e m pa-
c i e n t e s de h e m o d i á l i s e e pessoa l de r i s c o : 
A c o m p a n h a m e n t o de u m ano 
A r e s p o s t a i m u n e c o n t r a v a c i n a de hepa t i t e 
B ( C L B - 3 m g ) fo i a v a l i a d a e m 59 p a c i e n t e s de he -
m o d i á l i s e e 20 f u n c i o n á r i o s de r i sco e m a d q u i r i r 
i n f e c ç ã o . A s o r o c o n v e r s ã o fo i o b s e r v a d a e m 
52,5% e 70,0%, r e s p e c t i v a m e n t e . U m ano a p ó s 
a p r i m e i r a dose , os n í v e i s de a n t i c o r p o s a n t i - H B s 
f o r a m d e t e r m i n a d o s e m 37.5% dos p a c i e n t e s e 
60.0% d o s f u n c i o n á r i o s . O s n í v e i s de a n t i c o r p o s 
f o r a m e x p r e s s o s e m u n i d a d e s de r a d i o i m u n o e n ¬ 
sa io ( S R U = c o n t a g e m d a a m o s t r a sob re o c o n -
t ro le n e g a t i v o ) . C o n s i d e r a n d o a p e n a s os i nd i v í -
d u o s q u e r e s p o n d e r a m à v a c i n a , n o g r u p o de 
p a c i e n t e s , 38.7% t i v e r a m r e s p o s t a b a i x a de an t i -
c o r p o s (2,1 — 9,9 S R U ) , 32 ,3% r e s p o s t a m é d i a 
e 29,0% u m a r e s p o s t a e l e v a d a ( > S R U ) , e n q u a n ¬ 
to q u e no p e s s o a l de r i s c o , os v a l o r e s f o r a m 
14,3%, 64,3% e 21.4%, r e s p e c t i v a m e n t e . O s auto-
res s u g e r e m o u s o de v a c i n a s de H B V c o m c o n ¬ 
cen t rações de H B s A g m a i s e l e v a d a ou u m refor-
ço no e s q u e m a de i m u n i z a ç ã o p a r a m e l h o r a r a 
r e s p o s t a de a n t i - H B s , n ã o só p a r a p a c i e n t e s co¬ 
m o t a m b é m p a r a p e s s o a s s a d i a s . 
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We w i s h to t h a n k the c o l l a b o r a t i o n of D r s . 
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